Polar Asset Management Partners Inc. Adma Biologics, Inc. Transaction History

Polar Asset Management Partners Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 15, 2022	SELL	$1.43 - $2.2 $983,268 - $1.51 Million	-687,600 Reduced 53.4%	600,000 $1.19 Million
Q4 2021 Feb 14, 2022	BUY	$1.09 - $1.66 $1.4 Million - $2.14 Million	1,287,600 New	1,287,600 $1.82 Million

319

185M

917K

91.6K

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.91B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

Get notified when there are updates to the investment portfolio of Polar Asset Management Partners Inc., based on Form 13F filings with the SEC.

Stay updated on Polar Asset Management Partners Inc. with notifications on news.